Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |